{"transactions":[{"id":1560692,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2024-03-26T21:16:36.000Z","date":"2024-03-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":5560,"price":9.78,"value":54376.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of Common Shares withheld to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, as permitted by the Issuer's Performance and Restricted Share Unit Plan."}],"balance_after":211057,"source":{"system":"sec-edgar","filing":"0000950170-24-036578","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017024036578/ownership.xml","form_type":"4"}},{"id":1610174,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-29T21:45:44.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest and become exercisable in 48 equal monthly installments, with the first installment vesting on March 27, 2024, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":4.98,"expiration_date":"2034-02-26","underlying":"Common Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-24-023204","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017024023204/ownership.xml","form_type":"4"}},{"id":1700173,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2023-12-26T21:44:11.000Z","date":"2023-12-26","kind":"sale","planned":false,"acquired":false,"shares":5652,"price":3.63,"value":20516.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of Common Shares sold to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, pursuant to sell-to-cover elections."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average sales price. These shares were sold in multiple transactions on December 26, 2023 at prices ranging from $3.60 to $3.67 US Dollars. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":216617,"source":{"system":"sec-edgar","filing":"0000950170-23-073063","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017023073063/ownership.xml","form_type":"4"}},{"id":1773994,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2023-09-26T01:30:06.000Z","date":"2023-09-25","kind":"sale","planned":false,"acquired":false,"shares":3854,"price":3.58,"value":13797.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of Common Shares sold to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, pursuant to sell-to-cover elections."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price is a weighted average sales price. These shares were sold in multiple transactions on September 25, 2023 at prices ranging from $3.57 to $3.60 US Dollars. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":222269,"source":{"system":"sec-edgar","filing":"0000950170-23-049777","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017023049777/ownership.xml","form_type":"4"}},{"id":1773993,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2023-09-26T01:30:06.000Z","date":"2023-09-25","kind":"sale","planned":false,"acquired":false,"shares":1908,"price":3.57,"value":6811.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of Common Shares sold to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, pursuant to sell-to-cover elections."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average sales price. This represents the price in United States Dollars using the conversion rate on September 25, 2023. These shares were sold in multiple transactions on September 25, 2023 at prices ranging from $4.78 to $4.84 CAD Dollars. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":226123,"source":{"system":"sec-edgar","filing":"0000950170-23-049777","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017023049777/ownership.xml","form_type":"4"}},{"id":1795423,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2023-08-29T00:01:44.000Z","date":"2023-08-25","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":3.8,"value":76000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price is a weighted average sales price. These shares were sold in multiple transactions on August 25, 2023 at prices ranging from $3.76 to $3.87. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":228031,"source":{"system":"sec-edgar","filing":"0000950170-23-044853","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017023044853/ownership.xml","form_type":"4"}},{"id":1843524,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2023-06-27T22:53:27.000Z","date":"2023-06-27","kind":"sale","planned":false,"acquired":false,"shares":3941,"price":3.21,"value":12650.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of Common Shares sold to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, pursuant to sell-to-cover elections."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price is a weighted average sales price. These shares were sold in multiple transactions on June 27, 2023 at prices ranging from $3.20 to $3.23 US Dollars. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":248031,"source":{"system":"sec-edgar","filing":"0000950170-23-030242","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017023030242/ownership.xml","form_type":"4"}},{"id":1843523,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2023-06-27T22:53:27.000Z","date":"2023-06-27","kind":"sale","planned":false,"acquired":false,"shares":7694,"price":3.19,"value":24543.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of Common Shares sold to satisfy withholding tax obligations in connection with the settlement of vested restricted stock units, pursuant to sell-to-cover elections."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price is a weighted average sales price. This represents the price in United States Dollars using the conversion rate on June 27, 2023. These shares were sold in multiple transactions on June 27, 2023 at prices ranging from $4.20 to $4.23 CAD Dollars. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":251972,"source":{"system":"sec-edgar","filing":"0000950170-23-030242","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000095017023030242/ownership.xml","form_type":"4"}},{"id":1914952,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2023-04-24T23:34:33.000Z","date":"2023-03-14","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest in 16 equal quarterly installments beginning on June 14, 2023, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":259666,"source":{"system":"sec-edgar","filing":"0001209191-23-025476","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919123025476/doc4a.xml","form_type":"4/A","original_submission_date":"2023-03-17"}},{"id":1947285,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Shares","published_at":"2023-03-17T22:38:49.000Z","date":"2023-03-14","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest in 16 equal quarterly installments beginning on June 14, 2023, subject, to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":1445000,"source":{"system":"sec-edgar","filing":"0001209191-23-019890","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919123019890/doc4.xml","form_type":"4"}},{"id":2245047,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-03T20:06:44.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":1650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The option grant has an exercise price of $1.00 Canadian Dollars. This represents the exercise price in United States Dollars."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest and become exercisable, with 25% vesting on May 23, 2023, and 1/36th of the remaining shares vesting monthly thereafter over 36 months, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date."}],"balance_after":1650000,"derivative":{"exercise_price":0.78,"expiration_date":"2027-05-22","underlying":"Subordinate Voting Shares","underlying_shares":1650000},"source":{"system":"sec-edgar","filing":"0001209191-22-033984","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122033984/doc4a.xml","form_type":"4/A","original_submission_date":"2022-05-23"}},{"id":2245046,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Subordinate Voting Shares","published_at":"2022-06-03T20:06:44.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":1270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. Of these RSUs, 25% shall vest on May 23, 2023 with 1/12th of the remaining shares vesting each quarter thereafter over 12 quarters, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":1270000,"source":{"system":"sec-edgar","filing":"0001209191-22-033984","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122033984/doc4a.xml","form_type":"4/A","original_submission_date":"2022-05-23"}},{"id":2260224,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-23T21:53:12.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":1650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The option grant has an exercise price of $0.91 Canadian Dollars. This represents the exercise price in United States Dollars."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest and become exercisable, with 25% vesting on May 23, 2023, and 1/36th of the remaining shares vesting monthly thereafter over 36 months, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date."}],"balance_after":1650000,"derivative":{"exercise_price":0.71,"expiration_date":"2027-05-22","underlying":"Subordinate Voting Shares","underlying_shares":1650000},"source":{"system":"sec-edgar","filing":"0001209191-22-031402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122031402/doc4.xml","form_type":"4"}},{"id":2260223,"issuer":{"id":3884,"kind":"organization","name":"Definium Therapeutics, Inc.","symbol":"DFTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Subordinate Voting Shares","published_at":"2022-05-23T21:53:12.000Z","date":"2022-05-23","kind":"grant","acquired":true,"shares":1270000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. Of these RSUs, 25% shall vest on May 23, 2023 with 1/12th of the remaining shares vesting each quarter thereafter over 12 quarters, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date."}],"balance_after":1270000,"source":{"system":"sec-edgar","filing":"0001209191-22-031402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813814/000120919122031402/doc4.xml","form_type":"4"}},{"id":2473031,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-12-14T22:13:47.000Z","date":"2021-12-10","kind":"purchase","acquired":true,"shares":2231,"price":1.57,"value":3502.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":3883,"source":{"system":"sec-edgar","filing":"0001879785-21-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000187978521000035/edgar.xml","form_type":"4"}},{"id":2669739,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2021-06-14T21:03:39.000Z","date":"2021-06-10","kind":"purchase","acquired":true,"shares":652,"price":2.68,"value":1747.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":1652,"source":{"system":"sec-edgar","filing":"0001192482-21-000500","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000119248221000500/edgar.xml","form_type":"4"}},{"id":2825450,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":92658,"kind":"person","name":"Greenway Schond L.","position":1,"cik":"0001848205","reported_name":"Greenway Schond L.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & Treasurer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-01T22:14:21.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest over four years, with the first 25% vesting on the first anniversary of the grant date, and the remainder vesting in equal monthly installments over the following 36 months, subject to the reporting person's continued service on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":3.73,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001192482-21-000194","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000119248221000194/edgar.xml","form_type":"4"}}]}